The pharmaceutical company makes drugs to treat HIV, psoriasis, rheumatiod arthritis, low testosterone, thyroid problems, and Parkinson’s.
Looking for leads, investment insights, or competitive intelligence?
News about AbbVie
The new cure could be a boon to poorer nations.
AbbVie and Alector hope to apply immunotherapy to dementia and Alzheimer's.
Stocks are flourishing and IPOs abound.
AbbVie's victory is bad news for rival biotech giant Gilead.
If he pulls it off, he will make more than all of his peers combined.